dc.contributor.author | Mowatt, Graham | |
dc.contributor.author | Boachie, Charles | |
dc.contributor.author | Crowther, Mark | |
dc.contributor.author | Fraser, Cynthia Mary | |
dc.contributor.author | Hernandez, Rodolfo Andres | |
dc.contributor.author | Jia, Xueli | |
dc.contributor.author | Ternent, Laura | |
dc.date.accessioned | 2012-04-03T09:27:00Z | |
dc.date.available | 2012-04-03T09:27:00Z | |
dc.date.issued | 2009-09 | |
dc.identifier | 1132610 | |
dc.identifier | 00048cbf-d453-48e2-9a57-7fbf91a436e9 | |
dc.identifier | 000273002600010 | |
dc.identifier | 84886943103 | |
dc.identifier.citation | Mowatt , G , Boachie , C , Crowther , M , Fraser , C M , Hernandez , R A , Jia , X & Ternent , L 2009 , ' Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura ' , Health Technology Assessment , vol. 13 , no. Suppl 2 , pp. 63-68 . https://doi.org/10.3310/hta13suppl2/09 | en |
dc.identifier.issn | 2046-4924 | |
dc.identifier.uri | http://hdl.handle.net/2164/2374 | |
dc.format.extent | 6 | |
dc.format.extent | 759465 | |
dc.language.iso | eng | |
dc.relation.ispartof | Health Technology Assessment | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.3310/hta13suppl2/09 | |